News Focus
News Focus
Replies to #3231 on Biotech Values
icon url

rkrw

08/19/04 9:15 AM

#3233 RE: DewDiligence #3231

You're correct about ADHD. I scanned the PR. Could be a dosing issue, they under dosed before? Either way, imo this is a big deal for ceph. Early filing and differentiating the single isomer into a new indication is VERY good news for ceph.